#BiotechHangout is taking a break this week and will return next Friday, March 27.

While we’re away, stream the latest episodes on Spotify, Apple Podcasts, YouTube, Amazon Music, and BiotechHangout.com.

#BiotechHangout Sam Fazeli, Josh Schimmer, Paul Matteis, Graig Suvannavejh, on macro trends, Prasad, biotech's 50th, deals: Servier/$DAWN, $ABVX/$AZN, obesity: amylins, Ascletis, Hansoh/$REGN, China, data: $IDYA, Roche, $GSK, $BNTC, $RLMD, leucovorin, $DNTH, $VRTX, $XENE, $BNTX: bit.ly/3N0FKjx

#BiotechHangout: Eric Schmidt, Mike Yee, Yaron Werber, Matt Gline on market sentiment: macro conditions & volatility, company news: $ROIV / $MRNA settlement, $QURE & latest at FDA, $HROW, sandbagging, obesity news: consumer impact, GLP-1 brigade, Miami biotech conferences: bit.ly/47f1hM2

#BiotechHangout: Tess Cameron, Josh Schimmer, Brian Skorney, Adam Feuerstein on deals & financings: $GILD / $ACLX, China deal size, $VIR / Astellas, regulatory: $ATRA & Pierre Fabre, ARM CEO in NY Post, Makary on rare diseases, data: CagriSema, $GOSS, company news: $MRK, $SRPT, $XENE: bit.ly/4aZUQh5

#BiotechHangout is taking a break this week for President’s Day weekend & will return on Friday, Feb. 20, at 12pm ET. While we’re away, stream the latest episodes on Spotify, Apple Podcasts, Amazon Music, YouTube & BiotechHangout.com. We hope you enjoy the long weekend with friends & family!

#BiotechHangout: Josh Schimmer, Sam Fazeli, Brian Skorney, Yaron Werber, & BIO's John Crowley on D.C.: MFN, FDA, China ($AZN & CSPC deals), IRA list, market sentiment: IPO buzz, $IBB vs $XBI, investor sentiment survey, $EIKN IPO, deals: $MRK / $RVMD, $RGNX, data: $MRNA, Roche, $SRPT: bit.ly/4qcieNY

#BiotechHangout Grace Colon, Tim Opler, Graig Suvannavejh, Eric Schmidt on biopharma market outlook & sentiment, bull/bear debate, IPOs, deals: $GSK / $RAPT, $JANX / $BMY, policy: US exits WHO, NDAA bill updates for biotech, FDA myeloma guidelines, & $CRVS data & women’s health report bit.ly/4r3fGlY

#BiotechHangout: Chris Garabedian, Mike Yee, Paul Matteis, Sam Fazeli will recap #JPM26, 2026 kickoff, VC investing, company news: $ALNY, $MRNA, deals: $ABBV, AI, regulatory: FDA updates, $ATRA, obesity: $LLY, $AMGN, $ABBV, $BMY, other data: $LXEO, $BMRN, $JNJ, $VRTX & $SION, $LLY: bit.ly/3Zg2m1H

#BiotechHangout Sam Fazeli, Paul Matteis, Brian Skorney, Tess Cameron on market sentiment: $XBI & M&A, politics: peds vaccine update, deals: fundraising & IPO filing, $AZN/Jacobio, $ABBV/$RVMD, data: $CRNX, $ZBIO, $RARE, $NVO, $ARWR, $SNY, $NMRA, $GHRS, $ALMS, $DRUG & OL epilepsy data bit.ly/49elSld

#SponsorSpotlight: Syneos Health Communications is one of our #JPM26 Gold Badge sponsors! Thanks to them, enjoy an open bar at this free and open event. Learn more about Syneos: syneoshealthcommunications.com

Details & to register for the #BiotechHangout #JPM26 event: forms.gle/H7QLMfnqPKuq...

#BiotechHangout: Daphne Zohar, Bruce Booth, Eric Schmidt on market overview: $IMNM/$KYTX raising cash after data w/weak post-deal performance, '25 review &'26 expectations, policy: MFN, FDA staffing, mfg, PRVs, politicization of FDA, Ambros, $KYTX, $NKTR, STAT’s best/worst CEOs: bit.ly/48MB5cV

#BiotechHangout: Grace Colon, Chris Garabedian, Sam Fazeli, Paul Matteis, Yaron Werber, John Stanford on policy: NDAA provisions, industry trends: $1.85B in biotech financings, $XBI, $LLY’s acquisitive strategy, Fosun+$PFE, confs: #ASH25, #ESMOAsia, #SUO25, obesity data, Endpts 100: bit.ly/4q32CMO

RSVP now for our IRL networking event at #JPM26 hosted by #BiotechHangout & BiotechTV! Join us at Persona (685 Sutter St) on Jan. 13 from 7-10pm to mingle w/ biotech friends. Special thanks to our sponsors – CFGO, Syneos Health, Mispro, FTI Consulting, Catalytic Agency. Sign up now! bit.ly/4oKXL27

#BiotechHangout: Josh Schimmer, Brian Skorney, Paul Matteis, Graig Suvannavejh on ’26 outlook, Washington: FDA staffing, vaccines (leaked memo, COVID, former FDA heads NEJM article, ACIP), $QURE, AD agitation, $CAPR, $PRAX, data: $JANX, $BLTE, $PHVS, #ASH25, & Otsuka’s Voyxact price: bit.ly/4iCJt1P

#BiotechHangout will be taking a break this week to celebrate Thanksgiving. We will be back on December 5 at 12:00pm EST. Wishing you all a #HappyThanksgiving with loved ones and friends! While we’re away, listen to our latest episodes on biotechhangout.com, Spotify, Apple Podcasts, & YouTube.

#BiotechHangout: Eric Schmidt, Yaron Werber, Sam Fazeli, Tess Cameron on M&A: $ALKS/$AVDL, $JNJ/Halda, $MRK/$CDTX, policy: CDC website, RFK Jr. news, FDA/CDC outlook, pricing: $ARWR, $NVO's sema, $AGIO to engage FDA, regulatory paths & Elevidys’ label, data: $NUVL, $ZYME, Roche, $MRNA bit.ly/4pqcWOR

#BiotechHangout John Maraganore, Yaron Werber, Ami Fadia, Allison DeAngelis, Drew Armstrong on policy: MAHA summit, Pazdur to CDER, ‘plausible mechanism pathway’, deals: $DAWN/$MRSN, $PFE/$MTSR, Lundbeck/$AVDL, $MRK/$CDTX, data: $ALKS, $NBIX, $COGT, $KRRO, $CRSP, James Watson passing: bit.ly/4i0C6Rt

#BiotechHangout Graig Suvannavejh, Paul Matteis, Brian Skorney, Yaron Werber, Chris Garabedian, Adam Feuerstein on policy/regulatory: Tidmarsh out at FDA, $SRPT trial, $QURE in HD, $BHVN CRL, plus: Arena BioWorks, $NVO/$PFE/$MTSR escalation, $SLNO Q3 results, data: $CNTA/$HRMY, $TERN: bit.ly/47LE1oz

#BiotechHangout: Daphne Zohar, Bruce Booth, Sam Fazeli, Brian Skorney, Yaron Werber, Eric Schmidt on market updates/deals: $NVS/$RNA, $NVO/$PFE/$MTSR, $MRNA, women & M&A, generalists in biotech, YE bets, policy: FDA & biosimilars, $NVO, data: $NTLA, #ACR, $IONS/$ARGX, Bruce's lessons: bit.ly/4ol5YdU

#BiotechHangout: Chris Garabedian, Brian Skorney, Sam Fazeli on market sentiment, deals/financings: $ALKS/$AVDL, $SMMT, $ANRO & $NRIX, $TAK-Innovent, #ESMO25: Tubulis, $SMMT/Akeso, Exelixis, $INCY, $JNJ impact on $MRUS/$GMAB/$BCAX/$CRBP, TIGIT, data: $ALEC/$GSK, $VTYX, $ARCT, $MRNA: bit.ly/47oggCy

Mark your calendars! #BiotechHangout & @biotechtv.bsky.social will be back at #JPM26. Join us at Persona to meet up with biotech friends IRL on Tuesday, January 13 from 7-10pm. Interested in sponsoring? Email team@biotechhangout.com for more information. Additional registration information to come.

#BiotechHangout: Paul Matteis, John Maraganore, Eric Schmidt, Graig Suvannaveijh on market sentiment, breaking policy news, $BCRX/$ATXS, regulatory: $LEGN, FDA’s OAI letter to $NVO, $BCAX BTD, STAT Summit, company news: $REGN/Decibel, $XNCR, $PRAX, $MRUS/$GMAB, $ALEC, $CRBP, $TERN: bit.ly/4999wLn

#BiotechHangout, Tess Cameron, Brian Skorney, Sam Fazeli, Yaron Werber, Luba Greenwood, on deals & finance: $AKRO/$NOVO, $BMY/Orbital, $MPLT, $AZN/Algen, $SNY/BenchSci, Nilo, Ascenta, company news: $RCUS, $SKYE, $DYN, $IONS, regulatory: $LXEO, Peter Marks at $LLY, & board evolutions: bit.ly/48iUQJk

#BiotechHangout: Eric Schmidt, Sam Fazeli, Brian Skorney, Yaron Werber on macro: TrumpRx, MFN pricing/tariffs, $PFE/WH, $AZN to NYSE, $XBI, Tidmarsh posts, $IOBT cancer vaccine, $APLT stock, company news: $GMAB/$MRUS, $MLTX data, $LRMR & $ENTA data/stock, Q4 confs./earnings, $GSK CEO: bit.ly/4mSXokZ

#BiotechHangout: Sam Fazeli, Eric Schmidt, Paul Matteis, Brian Skorney & Brad Loncar on $XBI strong week, deals: $QURE, $MBX, $IMRX, $SNY, $PFE/$MTSR, data: $MBX, $ACAD, $PEPG, FDA ok for FORZINITY, $CDTX, $LLY, #ESMO25, policy: pharma tariffs, CRLs, $BMY price for Sotyktu, Tylenol: bit.ly/4nqVAAS

#BiotechHangout: Daphne Zohar, Josh Schimmer, Luba Greenwood, Matt Gline on market sentiment, Stifel report, deals: $NVO/$GLUE, $ETNB/Roche, data: $ATYR, $ROIV, Areteia, Apollo, policy: $JNJ sets price of Inlexzo, ACIP, HHS, Susan Monarez testimony, UK pharma exodus, interest rates: bit.ly/46uFwXo

#BiotechHangout Chris Garabedian, Tess Cameron, Eric Schmidt, Sam Fazeli, Brad Loncar on $LBRX IPO, $TRML, policy: China, DTC attack, $RNA data/offering, #WCLC: $SMMT, $TIL, $RVMD, $DNTH, regulatory: $ICPT, Capsida, $SLNO, $FGEN, $CAPR, $TVTX, Arena Bioworks CEO, $NVO layoffs bit.ly/46xsgm1

#BiotechHangout today: Paul Matteis, Sam Fazeli, John Maraganore, Graig Suvannaveijh cover $XBI & sector performance, readouts: $SNY, $UTHR, $IONS, $ARWR, upcoming data: $QURE, $HRMY, $SMMT, $AZN, themes: obesity, biomarkers, unique regulatory paths, & much more: twitter.com/i/spaces/1ea...

#BiotechHangout: Josh Schimmer, Eric Schmidt, Tess Cameron on policy: Prasad’s return, mRNA vaccine cuts cited for lack of public trust, investor blind spots, IPO drought, Q2 earnings wrap up, $SMMT volatility, $SPRY earnings, $AQST/RTW deal, data: $INSM, $SRPT & more: bit.ly/4lrqOpy

#BiotechHangout Grace Colon, John Maraganore, Paul Matteis, Eric Schmidt, Bruce Booth on mRNA, MFN/tariffs, Prasad, $SRRK data: $PRAX, $VRTX, $AGIO, $PFE, $LLY shifts: $NVO, Bayer earnings: $BBIO, TGTX, $MDGL, deals: $NVO/$RNA, $YMAB, $BIIB markets: $XOMA, OrbiMed, Gates $2.5B pledge bit.ly/4oz2sgz